Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain ...

San Francisco-based Rad AI, which develops generative AI (GenAI) tools to improve radiology workflows, has raised $60 million ...

Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain medicine in the US in more than 20 years.

Misinformation is becoming more prevalent with the rise of unregulated social media content. Combatting this and helping men ...

In a new pharmaphorum podcast with ZS Associates’ Sharon Karlsberg, principal and leader of oncology solutions, and Brandi ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now ...

Robert F Kennedy Jr's first confirmation hearing was a fractious affair, marked by tough questions about his prior ...

In Part 6 of the Life Sciences Industry Report, we’ve collated key thought leadership from 2024 that looks at ways in which ...

One explanation for the findings is that ECG data can help to predict the risk of stroke, which can contribute to age-related ...

The growing use of AI has opened new avenues for healthcare marketers, revolutionising how they approach new initiatives. With the Pharma 4.0 term representing the pharmaceutical industry's adaptation ...

President Trump will continue to pursue the policy of Medicare pricing negotiation introduced by former President Biden's Inflation Reduction Act (IRA), but will look at refining the programme.

Weber said it is the right time to appoint a successor, given the company's "competitive growth outlook, new product launches ...